Publications and communications of Claire Bernard

LOVINFOSSE, P., Ferreira, M., WITHOFS, N., JADOUL, A., Derwael, C., Frix, A.-N., GUIOT, J., BERNARD, C., Diep, A. N., Donneau, A.-F., LEJEUNE, M., BONNET, C., Vos, W., Meyer, P., & HUSTINX, R. (19 May 2022). Distinction of lymphoma from sarcoidosis at FDG PET/CT - evaluation of radiomic-feature guided machine learning versus human reader performance. Journal of Nuclear Medicine, 63, 1933-1940. doi:10.2967/jnumed.121.263598

Lamaye, C., Bastin, C., BERNARD, C., WITHOFS, N., HUSTINX, R., & SALMON, E. (April 2022). Analyse comparative de la distribution cérébrale du [18F]FDG dans une population de patients souffrant de maladie d’Alzheimer présentant ou non des antécédents familiaux de démence. Revue Médicale de Liège, 77 (4), 224-230.

Annen, J., Sala, A., Bonin, E., Sanz, L., Barra, A., Cecconi, B., Vitello, M., Szymkowicz, E., Cardone, P., BERNARD, C., Martial, C., LAUREYS, S., Gosseries, O., & Thibaut, A. (2021). FDG-PET/CT data of healthy volunteers and patients with disorders of consciousness. doi:10.25493/7TXP-WCF

Bastin, C., Bahri, M. A., BERNARD, C., HUSTINX, R., & Salmon, E. (2021). Frontal hypometabolism in neurocognitive disorder with behavioral disturbance. Journal of Nuclear Medicine, 62, 1783-1788.

Da Silva Ferreira, M., LOVINFOSSE, P., HERMESSE, J., DE CUYPERE, M., Rousseau, C., Lucia, F., Schick, U., Reinhold, C., Robin, P., Hatt, M., Visvikis, D., Bernard, C., Leijenaar, R. T. H., Kridelka, F., Lambin, P., Meyer, P., & Hustinx, R. (2021). [(18)F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05303-5

JADOUL, A., Bernard, C., LOVINFOSSE, P., GERARD, L., LILET, H., Cornet, O., & Hustinx, R. (2020). Comparative dosimetry between (99m)Tc-MAA SPECT/CT and (90)Y PET/CT in primary and metastatic liver tumors. European Journal of Nuclear Medicine and Molecular Imaging, 47 (4), 828-837. doi:10.1007/s00259-019-04465-7

Meyers, N., JADOUL, A., BERNARD, C., DELWAIDE, J., LAMPROYE, A., DETRY, O., HONORE, P., GERARD, L., & HUSTINX, R. (2020). Inter-observer variability of 90Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization. EJNMMI Research. doi:10.1186/s40658-020-00302-1

Da Silva Ferreira, M., LOVINFOSSE, P., DE CUYPERE, M., Rovira, R., Lucia, F., Schick, U., Vallières, M., Bonaffini, P., Reinhold, C., Visvikis, D., Hatt, M., BERNARD, C., Leijenaar, R., Walsh, S., KRIDELKA, F., Meyer, P., & HUSTINX, R. (29 November 2019). FDG PET radiomics to predict disease free survival in Cervical Cancer [Paper presentation]. Bioforum Liege 2019.

Da Silva Ferreira, M., LOVINFOSSE, P., DE CUYPERE, M., Rovira, R. R., Lucia, F., Schick, U., Vallières, M., Bonaffini, P., Reinhold, C., Visvikis, D., Hatt, M., BERNARD, C., Leijenaar, R., Walsh, S., KRIDELKA, F., Meyer, P., & HUSTINX, R. (02 November 2019). FDG PET radiomics to predict disease free survival in Cervical Cancer [Paper presentation]. 2019 IEEE Nuclear Science Symposium & Medical Imaging Conference.

Da Silva Ferreira, M., LOVINFOSSE, P., DE CUYPERE, M., Rovira, R., Lucia, F., Schick, U., Vallières, M., Bonaffini, P., Reinhold, C., Visvikis, D., Hatt, M., BERNARD, C., Leijenaar, R., Walsh, S., KRIDELKA, F., Meyer, P., & HUSTINX, R. (September 2019). Radiomics for Disease Free Survival prediction using pre-treatment FDG PET images [Paper presentation]. "Imaging of diagnostic and therapeutic biomarkers in Oncology“ workshop Manoir de Kerdréan, Le Bono, France, September 25th- 28th, 2019.

Thibaut, A., Moissenet, F., Di Perri, C., Schreiber, C., Remacle, A., Kolanowski, E., CHANTRAINE, F., BERNARD, C., HUSTINX, R., Tshibanda, J.-F., Filipetti, P., Laureys, S., & Gosseries, O. (2017). Brain plasticity after implanted peroneal nerve electrical stimulation to improve gait in chronic stroke patients: Two case reports. NeuroRehabilitation, 40 (2), 251-258. doi:10.3233/NRE-161410

Verger, E., Drion, P., MEFFRE, G., BERNARD, C., Duwez, L., Lepareur, N., Couturier, O., Hindré, F., HUSTINX, R., & Lacoeuille, F. (2016). 68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies. PLoS ONE. doi:10.1371/journal.pone.0164626

Annen, J.* , Heine, L.* , Ziegler, E., Frasso, G., Bahri, M. A., Di Perri, C., Stender, J., Martial, C., Wannez, S., D'Ostilio, K., Amico, E., Antonopoulos, G., BERNARD, C., TSHIBANDA, L., HUSTINX, R., & Laureys, S. (06 June 2016). Function–structure connectivity in patients with severe brain injury as measured by MRI-DWI and FDG-PET. Human Brain Mapping, 37 (11), 3707-3720. doi:10.1002/hbm.23269

Verger, E., Drion, P., MEFFRE, G., BERNARD, C., Bouvier, A., Lepareur Nicolas, Couturier, O., Hindré, F., HUSTINX, R., & Lacoeuille, F. (May 2016). Microparticules à base d’amidon radiomarquées au 188Re et 68Ga comme agent théranostique pour la radiothérapie interne sélective du carcinome hépatocellulaire. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 40 (3), 182. doi:10.1016/j.mednuc.2016.03.035

Verger, E., Drion, P., MEFFRE, G., BERNARD, C., Duwez, L., Lepareur, N., Couturier, O., Hindré, F., Lacoeuille, F., & HUSTINX, R. (01 May 2016). 188Re and 68Ga radiolabeled Starch-Based Microparticles as potential theranostic radiopharmaceutical for Hepatocellular Carcinoma. Journal of Nuclear Medicine, 57 (suppl. 2).

LOVINFOSSE, P., Janvary, Z. L., COUCKE, P., JODOGNE, S., BERNARD, C., Hatt, M., Visvikis, D., JANSEN, N., DUYSINX, B., & HUSTINX, R. (2016). FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-016-3314-8

Antonopoulos, G., Wannez, S., Thibaut, A., Bahri, M. A., HUSTINX, R., BERNARD, C., Bruno, M.-A., Chatelle, C., Luxen, A., Phillips, C., Maquet, P., & Laureys, S. (22 June 2015). Diagnostic accuracy of cerebral metabolic imaging in disorders of consciousness [Poster presentation]. 1st Congress of the European Academy of Neurology 2015, Berlin, Germany.

Wannez, S., Thibaut, A., Vitali-Roscini, G., Di Perri, C., Bruno, M.-A., Chatelle, C., BERNARD, C., HUSTINX, R., MAQUET, P., Majerus, S., & Laureys, S. (21 June 2015). Recovery of language comprehension in the minimally conscious state studied by FDG-PET [Poster presentation]. 1st Congress of the European Academy of Neurology, Berlin, Germany.

Antonopoulos, G., Wannez, S., Thibaut, A., Bahri, M. A., HUSTINX, R., Bernard, C., Bruno, M.-A., Chatelle, C., Luxen, A., Phillips, C., & Laureys, S. (17 June 2015). Automatic Classification of FDG-PET imaging data in Disorders of Consciousness [Poster presentation]. 21 ST ANNUAL MEETING OF THE ORGANIZATION FOR HUMAN BRAIN MAPPING, Honolulu, Hawaii, United States.

Annen, J., Heine, L., Ziegler, E., Stender, J., Bahri, M. A., Wannez, S., Bruno, M.-A., Thibaut, A., BERNARD, C., Antonopoulos, G., Di Perri, C., Martial, C., Amico, E., Demertzi, A., Salmon, E., Maquet, P., TSHIBANDA, L., HUSTINX, R., & Laureys, S. (June 2015). Multimodal characterization of default mode network structure and metabolism in patients with disorders of consciousness using diffusion weighted-MRI and 18F-FDG-PET [Poster presentation]. 1st Congress of the European Academy of Neurology, Berlin, Germany.

Bretin, F., Bahri, M. A., BERNARD, C., Warnock, G., Aerts, J., Mestdagh, N., Buchanan, T., Otoul, C., Koestler, F., Mievis, F., Giacomelli, F., Degueldre, C., Hustinx, R., Luxen, A., Seret, A., Plenevaux, A., & Salmon, E. (17 January 2015). Biodistribution and radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H: First-in-human study. Molecular Imaging and Biology, 17, 557-564. doi:10.1007/s11307-014-0820-6

Salmon, E., Bernard, C., & HUSTINX, R. (2015). Pitfalls and Limitations of PET/CT in Brain Imaging. Seminars in Nuclear Medicine, 45 (6), 541-51. doi:10.1053/j.semnuclmed.2015.03.008

Stender, J., Kupers, R., Rodell, A., Thibaut, A., Chatelle, C., Bruno, M.-A., Gejl, M., Bernard, C., HUSTINX, R., Laureys, S., & Gjedde, A. (2015). Quantitative rates of brain glucose metabolism distinguish minimally conscious from vegetative state patients. Journal of Cerebral Blood Flow and Metabolism, 35 (1), 58-65. doi:10.1038/jcbfm.2014.169

Thibaut, A., Di Perri, C., Chatelle, C., Bruno, M.-A., Bahri, M. A., Wannez, S., Piarulli, A., BERNARD, C., Martial, C., Heine, L., HUSTINX, R., & Laureys, S. (2015). Clinical Response to tDCS Depends on Residual Brain Metabolism and Grey Matter Integrity in Patients With Minimally Conscious State. Brain Stimulation, 8 (6), 1116-23. doi:10.1016/j.brs.2015.07.024

Chatelle, C., Thibaut, A., Bruno, M.-A., Boly, M., Bernard, C., Hustinx, R., Schnakers, C., & Laureys, S. (2014). Nociception coma scale-revised scores correlate with metabolism in the anterior cingulate cortex. Neurorehabilitation and Neural Repair, 28 (2), 149-52. doi:10.1177/1545968313503220

Chatelle, C.* , Thibaut, A.* , Gosseries, O., Bruno, M.-A., Demertzi, A., BERNARD, C., HUSTINX, R., TSHIBANDA, L., Bahri, M. A., & Laureys, S. (2014). Changes in cerebral metabolism in patients with a minimally conscious state responding to zolpidem. Frontiers in Neuroscience, 8, 917. doi:10.3389/fnhum.2014.00917

Thibaut, A., Chatelle, C., Stender, J., Demertzi, A., BERNARD, C., HUSTINX, R., LAUREYS, S., & Bruno, M.-A. (2014). Positron emission tomography imaging in altered states of consciousness: Coma, sleep and hypnosis. In R. Dierckx, A. Otte, E. Vries, A. Waarde, ... K. Leenders (Eds.), PET and SPECT in Neurology (pp. 965-986). Paris, France: Springer.

WITHOFS, N., BERNARD, C., VAN DER REST, C., MARTINIVE, P., HATT, M., JODOGNE, S., VISVIKIS, D., LEE, J. A., COUCKE, P., & HUSTINX, R. (2014). FDG PET/CT for rectal carcinoma radiotherapy treatment planning : Comparison of functional volume delineation algorithms and clinical challenges. Journal of Applied Clinical Medical Physics, 15 (5), 216-228. doi:10.1120/jacmp.v15i5.4696

Guiot, T., Vanderlinden, B., Seret, A., van Elmbt, L., Bol, A., Trotta, N., Keppens, J., George, J., Lambrechts, M., Lavent, F., Pareyn, J., Alberty, J., Destiné, M., BERNARD, C., Greffe, J.-L., Garcia, C., & Flamen, P. (25 May 2013). Lesion size effect on variability in PET quantification in multicenter trials [Poster presentation]. 16th Symposium of the Belgian Society of Nuclear Medicine, Ostend, Belgium.

Charland-Verville, V., Bruno, M.-A., Bahri, M. A., Demertzi, A., Desseilles, M., Chatelle, C., Vanhaudenhuyse, A., HUSTINX, R., BERNARD, C., TSHIBANDA, L., Laureys, S., & Zeman, A. (12 April 2013). Brain dead yet mind alive: A positron emission tomography case study of brain metabolism in Cotard’s syndrome. Cortex: A Journal Devoted to the Study of the Nervous System and Behavior, 49 (7), 1997-1999. doi:10.1016/j.cortex.2013.03.003

JODOGNE, S., Bernard, C., DEVILLERS, M., LENAERTS, E., & Coucke, P. (2013). Orthanc - A lightweight, RESTful DICOM server for healthcare and medical research. Proceedings, IEEE International Symposium on Biomedical Imaging: from Nano to Macro, 190-193. doi:10.1109/ISBI.2013.6556444

Bernard, C., Paulus, C., JODOGNE, S., & Hustinx, R. (2013). Automated platform for the quality control of PET-CT scanners following AFCN/FANC recommendations. In Proceedings of the Belgian Hospital Physicists Association Symposium.

Hauzeur, J.-P., Bernard, C., Egrise, D., Kurth, W., Van Cauwenberge, H., LECHANTEUR, C., Gillet, P., Beguin, Y., MALAISE, M., & HUSTINX, R. (2013). (111)Indium-oxine labelling for evaluating the homing process of autologous osteoblasts implanted percutaneously in atrophic nonunion fractures. International Orthopaedics, 37 (1), 131-6. doi:10.1007/s00264-012-1719-y

Seret, A., Nguyen, D., & BERNARD, C. (27 August 2012). Quantitative capabilities of four state-of-the-art SPECT-CT cameras. EJNMMI Research, 2, 45. doi:10.1186/2191-219X-2-45

Bruno, M.-A., Majerus, S., Boly, M., Vanhaudenhuyse, A., Schnakers, C., Gosseries, O., Boveroux, P., KIRSCH, M., Demertzi, A., Bernard, C., Hustinx, R., Moonen, G., & Laureys, S. (2012). Functional neuroanatomy underlying the clinical subcategorization of minimally conscious state patients. Journal of Neurology, 259 (6), 1087-98. doi:10.1007/s00415-011-6303-7

Chatelle, C., Thibaut, A., Gosseries, O., Thonnard, M., BERNARD, C., HUSTINX, R., LAUREYS, S., & Bruno, M.-A. (2012). Zolpidem effect on recovery of consciousness: a FDG-PET study [Poster presentation]. Belgian Brain Congress, Liège, Belgium.

MINON, A., CABAY, J.-E., DEMEZ, P., Bernard, C., MOREAU, P., & HUSTINX, R. (2012). Nodal staging of head and neck squamous cell carcinomas : impact of a dedicated PET/CT protocol. Journal of Nuclear Medicine, 53 (SUPPL), 1354.

Thibaut, A., Bruno, M.-A., Chatelle, C., Gosseries, O., Vanhaudenhuyse, A., Demertzi, A., Schnakers, C., Thonnard, M., CHARLAND-VERVILLE, V., BERNARD, C., Bahri, M. A., Phillips, C., Boly, M., Hustinx, R., & Laureys, S. (2012). Metabolic activity in external and internal awareness networks in severely brain-damaged patients. Journal of Rehabilitation Medicine, 44 (6), 487-94. doi:10.2340/16501977-0940

Bernard, C., Nguyen, D., & Seret, A. (27 October 2011). Quantitative capabilities of current commercial SPECT-CT systems [Poster presentation]. IEEE Nuclear Science Symposium and Medical Imaging Conference, Valence, Spain.

Guiot, T., Vanderlinden, B., Wimana, Z., Seret, A., van Elmbt, L., Bol, A., Trotta, N., Keppens, J., Geoerges, J., Lambrechts, M., Lavent, F., Pareyn, J., Alberty, J., Destine, M., BERNARD, C., Greffe, J.-L., Garcia, C. A., Hendlisz, A., Buvat, I., & Flamen, P. (October 2011). Phantom program analysis to assess the variability in PET image quantification between different PET-CT centres. European Journal of Nuclear Medicine and Molecular Imaging, 38 (S2), 172.

Nguyen, D., Dalemans, C., Bahri, M. A., Salmon, E., BERNARD, C., & Seret, A. (October 2011). Viability for the Siemens Ecat HR+ of the new stability test of PET scanners elaborated by the Belgian Hospital Physicist Association. European Journal of Nuclear Medicine and Molecular Imaging, 38 (S2), 174.

Nguyen, D., Seret, A., & Bernard, C. (October 2011). Quantitative capabilities of the Siemens Symbia T6 SPECT-CT system with iterative Flash3D reconstruction. European Journal of Nuclear Medicine and Molecular Imaging, 38 (S2), 223.

Seret, A., Dalemans, C., Nguyen, D., & BERNARD, C. (07 May 2011). Viabilité pour le Siemens ECAT EXACT HR+ du test de stabilité des tomographes TEP élaboré par la société belge des physiciens d'hôpitaux. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 35, 288.

Seret, A., Nguyen, D., HUSTINX, R., & BERNARD, C. (07 May 2011). Potentialités quantitatives et qualité d'image de la camera TEMP/TDM Siemens Symbia T6. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 35, 289.

WITHOFS, N., Bernard, C., VAN DER REST, C., MARTINIVE, P., HATT, M., Dimitris, V., COUCKE, P., & HUSTINX, R. (2011). FDG PET/CT for radiotherapy treatment planning. Comparison of functional volume delineation algorithms. Journal of Nuclear Medicine.

Bernard, C., NGuyen, T., & Seret, A. (February 2007). Impact of scatter and attenuation correction methods on hot and cold contrasts obtained with the Philips Gemini PET-scanner [Poster presentation]. 22th Annual Symposium of the Belgian Hospital Physicist Association, Liège, Belgium.

Seret, A., Nguyen, T., & Bernard, C. (2006). Impact of the attenuation and scatter correction methods on hot and cold contrasts obtained with the Philips Gemini PET-scanner. European Journal of Nuclear Medicine and Molecular Imaging, 33 (S2), 316.